Diagonal Bio
0,012
SEK
-3,33 %
Mindre end 1K følgere
DIABIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
-3,33%
-30,12%
+7,51%
-29,46%
+4,98%
-73,23%
-98,76%
-
-99,67%
Diagonal Bio operates in the biotechnology industry. The company is developing a platform under the name Panviral to detect and diagnose small sections of pathogen genomes, such as viruses, bacteria, and fungi. In addition to the main business, service and associated ancillary services are also offered. The largest operations take place in Sweden with headquarter in Lund.
Læs mereMarkedsværdi
14,09 mio. SEK
Aktieomsætning
42,32 t SEK
Omsætning
20 t
EBIT %
-57.850 %
P/E
-
Udbytteafkast, %
-
Finanskalender
28.3
2025
Årsrapport '24
14.5
2025
Delårsrapport Q1'25
20.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Diagonal Bio AB: Diagonal Bio has received conditional approval for listing on NGM Nordic SME
Diagonal Bio AB: Diagonal Bio applies for change of marketplace to NGM Nordic SME
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools